CALCA and thyroid nodule: Based on the results of a rat study, a black box warning was issued in the United States in the prescribing information for tirzepatide, alerting patients to the risk of thyroid C-cell tumors and recommending further evaluation in patients with significantly elevated calcitonin levels or those found to have thyroid nodules.